Alcohol Dependence Clinical Trial
Official title:
The Effect of Nitrate on Cognitive Function in Alcohol Dependence Patients and the Potential Microbiota Mechanism.
Alcohol use is increasingly prevalent in modern society and is known to cause cognitive impairment and dysregulation of inflammatory responses. In the present study, the investigators want to perform a randomised controlled trials to test whether nitrate could change the oral microbiota and benefit the cognitive impairment in alcohol dependence patients. The investigators survey the oral bacterial communities in saliva samples of 70 alcohol dependent patients following 14 days of dietary inorganic nitrate (nitrate-rich beetroot juice, ~750 mg NO3- /d) and placebo (nitrate-depleted beetroot juice, ~1 mg NO3- /d) supplementation.
Status | Recruiting |
Enrollment | 70 |
Est. completion date | August 7, 2024 |
Est. primary completion date | August 7, 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: 1. Han nationality 2. Montreal Cognitive Assessment(MoCA) score >11 3. Diagnosis of alcohol dependence Exclusion Criteria: 1. Past or current infectious disease 2. Past or current heart, brain, liver, kidney, and other severe diseases 3. Past or current metabolic diseases that can lead to abnormalities of the immune system, such as obesity (Body Mass Index > 30 kg/m2), diabetes, or rheumatoid arthritis 4. Past or current neurodegenerative diseases, such as Parkinson's disease 5. Use of steroidal and non-steroidal anti-inflammatory drugs, antibiotics, antioxidants, and immunosuppressive agents within two months of enrollment 6. Use of probiotics and probiotics every day for the first two months before enrollment 7. Previous or current DSM-IV diagnosis of schizophrenia, depression, anxiety disorder, bipolar disorder, mental retardation, dementia (excluding mild cognitive impairment, MCI), or substance dependence other than alcohol and nicotine 8. Irregular eating habits that affect the oral flora (except alcohol) in the previous two months 9. Current oral disease |
Country | Name | City | State |
---|---|---|---|
China | Anhui mental health center | Hefei | Anhui |
Lead Sponsor | Collaborator |
---|---|
Peking University Sixth Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Systolic and diastolic blood pressure | Test by blood pressure monitor | baseline and post-intervention (two weeks after baseline test) | |
Other | Cytokine Tumor Necrosis Factor-a in serum | The collected serum samples were used to test the levels of TNF-a by Enzyme-Linked Immunosorbent Assay | baseline and post-intervention(two weeks after baseline test) | |
Other | The blood biochemical related parameters includes liver enzymes (alanine aminotransferase and aspartate aminotransferase) | The collected venous blood were sent to the department of clinical laboratory and the investigators recorded the laboratory report. | baseline and post-intervention (two weeks after baseline test) | |
Other | The blood biochemical related parameters blood fat (cholesterol, triglycerides, low density lipoprotein and high density lipoprotein | The collected venous blood were sent to the department of clinical laboratory and the investigators recorded the laboratory report. | baseline and post-intervention (two weeks after baseline test) | |
Other | Cytokine Interleukin-1b in serum | The collected serum samples were used to test the levels of IL-1b by Enzyme-Linked Immunosorbent Assay | baseline and post-intervention(two weeks after baseline test) | |
Other | Cytokine Interleukin-6 in serum | The collected serum samples were used to test the levels of IL-6 by Enzyme-Linked Immunosorbent Assay | baseline and post-intervention (two weeks after baseline test) | |
Other | Cytokine Interleukin-10 in serum | The collected serum samples were used to test the levels of IL-10 by Enzyme-Linked Immunosorbent Assay | baseline and post-intervention (two weeks after baseline test) | |
Primary | Changes of Delayed Match to Sample Percent Correct (all delays) from baseline to post-intervention | Test by DMS-PCAD (Delayed Match to Sample Percent Correct , all delays) | baseline and post-intervention(two weeks after baseline test) | |
Primary | Changes of Spatial Working Memory Between Errors from baseline to post-intervention | Test by SWM-BE (The Spatial Working Memory Between Errors ) | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of oral microbiota from baseline to post-intervention | Saliva samples were used to test the composition of microbiota by 16S RNA sequencing. | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of gut microbiota from baseline to post-intervention | Feces samples were used to test the composition of microbiota by 16S RNA sequencing. | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Delayed Match to Sample Percent Correct (0 seconds delay) from baseline to post-intervention | Test by Delayed Match to Sample Percent Correct (0 seconds delay) | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Delayed Match to Sample Percent Correct (4 seconds delay) from baseline to post-intervention | Test by Delayed Match to Sample Percent Correct (4 seconds delay) | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Delayed Match to Sample Percent Correct (12 seconds delay) from baseline to post-intervention | Test by Delayed Match to Sample Percent Correct (12 seconds delay) | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Spatial Working Memory errors 4 boxes from baseline to post-intervention | Test by The Spatial Working Memory errors 4 boxes | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Spatial Working Memory errors 6 boxes from baseline to post-intervention | Test by The Spatial Working Memory errors 6 boxes | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Spatial Working Memory errors 8 boxes from baseline to post-intervention | Test by The Spatial Working Memory errors 8 boxes | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Intra-Extra Dimensional Set Shift test Stages Completed from baseline to post-intervention | Test by The Intra-Extra Dimensional Set Shift test Stages Completed | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Intra-Extra Dimensional Completed Stage Errors from baseline to post-intervention | Test by The Intra-Extra Dimensional Completed Stage Errors | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Cambridge Gambling Task Risk Adjustment Merged: Risk adjustment from baseline to post-intervention | Test by Cambridge Gambling Task Risk Adjustment Merged: Risk adjustment | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Cambridge Gambling Decision Making Quality Total Merged from baseline to post-intervention | Test by Cambridge Gambling Decision Making Quality Total Merged | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Cambridge Gambling Delay Aversion Total from baseline to post-intervention | Test by Cambridge Gambling Delay Aversion Total | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Reaction Time Median Five-Choice Movement Time from baseline to post-intervention | Test by Reaction Time Median Five-Choice Movement Time | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Reaction Time Median Five-Choice Reaction Time from baseline to post-intervention | Test by Reaction Time Median Five-Choice Reaction Time | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Rapid Visual Information Processing test Probability of False Alarm from baseline to post-intervention | Test by the Rapid Visual Information Processing test Probability of False Alarm | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Rapid Visual Information Processing test A prime from baseline to post-intervention | Test by the Rapid Visual Information Processing test A prime | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of Rapid Visual Information Processing test Median Response Latency from baseline to post-intervention | Test by the Rapid Visual Information Processing test Median Response Latency | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of nitrate levels in serum from baseline to post-intervention | The collected serum samples were used to test the levels of nitrate and nitrite by High Performance Liquid Chromatography \ HPLC | baseline and post-intervention(two weeks after baseline test) | |
Secondary | Changes of nitrite levels in serum from baseline to post-intervention | The collected serum samples were used to test the levels of nitrate and nitrite by High Performance Liquid Chromatography \ HPLC | baseline and post-intervention(two weeks after baseline test) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |